Back
Tango Therapeutics Quote, Financials, Valuation and Earnings
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Buy
54
TNGX
Tango Therapeutics
Last Price:
8.28
Seasonality Move:
27.24%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Tango Therapeutics Price Quote
$8.28
-0.34 (-3.94%)
(Updated: September 18, 2024 at 6:55 PM ET)
Tango Therapeutics Key Stats
Buy
54
Tango Therapeutics (TNGX)
is a Buy
Day range:
$8.04 - $9.84
52-week range:
$5.15 - $13.03
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21.19
P/B ratio:
3.73%
Volume:
2M
Avg. volume:
937.2K
1-year change:
1.29%
Market cap:
$923.6M
Revenue:
$36.5M
EPS:
$-1.12
How Much Does Tango Therapeutics Make?
-
How Much Are Tango Therapeutics's Sales Annually?
TNGX Revenues are $36.5M -
How Much Profit Does Tango Therapeutics's Make A Year?
TNGX net income is -$101.7M
Is Tango Therapeutics Growing As A Company?
-
What Is Tango Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.36% -
What Is Tango Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Tango Therapeutics Stock Price Performance
-
Did Tango Therapeutics Stock Go Up Last Month?
Tango Therapeutics share price went down by -13.45% last month -
Did TNGX's Share Price Rise Over The Last Year?
TNGX share price rose by 1.29% over the past 1 year
What Is Tango Therapeutics 52-Week High & Low?
-
What Is Tango Therapeutics’s 52-Week High Share Price?
Tango Therapeutics has traded as high as $13.03 over the past 52 weeks -
What Is Tango Therapeutics’s 52-Week Low Share Price?
Tango Therapeutics has traded as low as $5.15 over the past 52 weeks
Tango Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Tango Therapeutics?
-
How Much Debt Does Tango Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Tango Therapeutics Have?
Cash and short term investments quarterly total is $322.1M -
What Is Tango Therapeutics’s Book Value Per Share?
Book value per share is 2.31
Is Tango Therapeutics Cash Flow Positive?
-
What Is TNGX Cash Flow From Operations?
Cash flow from operations (TTM) is -$120.1M -
What Is Tango Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $126M -
What Is Tango Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$21.3M
Tango Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
TNGX return on invested capital is -46.42% -
What Is Tango Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -29.16% -
What Is TNGX Return On Equity?
ROE is a measure of profitability and is -46.42%
Tango Therapeutics Earnings Date & Stock Price
-
What Is Tango Therapeutics's Stock Price Today?
A single share of TNGX can be purchased today for 8.62 -
What Is Tango Therapeutics’s Stock Symbol?
Tango Therapeutics trades on the nasdaq under the ticker symbol: TNGX -
When Is Tango Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Tango Therapeutics is scheduled on November 8, 2024 -
When Is TNGX's next ex-dividend date?
Tango Therapeutics's next ex-dividend date is September 18, 2024 -
How To Buy Tango Therapeutics Stock?
You can buy Tango Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Tango Therapeutics Competitors
-
Who Are Tango Therapeutics's Competitors?
Below is a list of companies who compete with Tango Therapeutics or are related in some way:
Tango Therapeutics Dividend Yield
-
What Is TNGX Dividend Yield?
Tango Therapeutics’s dividend yield currently is 0% -
What Is Tango Therapeutics’s Payout Ratio?
Tango Therapeutics’s payout ratio is 0% -
When Did Tango Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 18, 2024 -
What Is Tango Therapeutics’s Dividend Per Share?
Tango Therapeutics pays a dividend of $0.00 per share
Tango Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 31.67% |
| Revenue: | 36.15% | 160.42% |
Analyst Recommendations
| Buy Recommendations: | 6 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 16.13 |
| Upside from Last Price: | 87.06% |